Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1000
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1000
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

865
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
865

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Imaging of the Corneal Endothelial Transition Zone Reveals Progenitor Cell Population.

Cells·2025
Same author

[Uveal effusion syndrome due to immune-mediated reaction to pembrolizumab].

Die Ophthalmologie·2025
Same author

The Biocompatibility Analysis of Artificial Mucin-Like Glycopolymers.

International journal of molecular sciences·2023
Same author

[Evaluation of corneal biomechanics in keratoconus using dynamic ultra-high-speed Scheimpflug measurements].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

[Critical endothelial procedures during posterior lamellar graft preparation and transplantation].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

[Protection of corneal endothelium from apoptosis by gene and cell therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016

Related Experiment Video

Updated: Dec 11, 2025

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.7K

[Acute angle-closure glaucoma and effusion syndrome after phacoemulsification].

M Anwar1, T Brockmann2, M Walckling2

  • 1Klinik und Poliklinik für Augenheilkunde, Universitätsmedizin Rostock, Doberaner Str. 140, 18057, Rostock, Deutschland. mahmoud.anwar@med.uni-rostock.de.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|August 18, 2020
PubMed
Summary

Acetazolamide can cause rare but severe uveal effusion syndrome after cataract surgery. Prompt sulfonamide-free treatment led to rapid ocular improvement in a glaucoma patient.

Keywords:
AcetazolamideAdverse drug reactionCataract surgerySulfonamide allergyUveal effusion syndrome

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.5K
Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

2.8K

Related Experiment Videos

Last Updated: Dec 11, 2025

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.7K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.5K
Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

2.8K

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Cataract surgery is a common procedure with potential complications.
  • Glaucoma and uveal effusion syndrome are serious ocular conditions.

Observation:

  • A 72-year-old female developed bilateral secondary angle-closure glaucoma with uveal effusion syndrome post-cataract surgery.
  • Acetazolamide, a sulfonamide medication, was identified as the likely cause.

Findings:

  • The patient experienced a rare adverse effect of acetazolamide.
  • Sulfonamide-free systemic and local treatments for intraocular pressure and inflammation were initiated.

Implications:

  • This case highlights a severe, albeit uncommon, side effect of acetazolamide.
  • Effective management involves prompt cessation of the causative agent and appropriate anti-glaucoma and anti-inflammatory therapies.